Bzdok, J., Czibere, L., Burggraf, S., Landt, O., Maier, E. M., Röschinger, W., . . . Durner, J. (2024). Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophy. PLoS ONE, 19(6), 1. https://doi.org/10.1371/journal.pone.0306329
Chicago Style (17th ed.) CitationBzdok, Jessica, et al. "Quality Considerations and Major Pitfalls for High Throughput DNA-based Newborn Screening for Severe Combined Immunodeficiency and Spinal Muscular Atrophy." PLoS ONE 19, no. 6 (2024): 1. https://doi.org/10.1371/journal.pone.0306329.
MLA (9th ed.) CitationBzdok, Jessica, et al. "Quality Considerations and Major Pitfalls for High Throughput DNA-based Newborn Screening for Severe Combined Immunodeficiency and Spinal Muscular Atrophy." PLoS ONE, vol. 19, no. 6, 2024, p. 1, https://doi.org/10.1371/journal.pone.0306329.